40 completed, 16 recruiting, 10 unknown, 7 terminated. 86 Phase 2, 14 Phase 3, 13 Phase 1.
Follow Dronabinol: new trials by email Literature Review of Dronabinol trials Research Report on Dronabinol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Of Synthetic THC And Sleep Dronabinol, Placebo - Obstructive Sleep Apnea | Phase 2 / Phase 3 | Not yet recruiting | Mayo Clinic | 72 | 2026-11-01 | 2026-09-18 |
| Synthetic THC And Blood Pressure Dronabinol, Placebo - Blood Pressure | Phase 2 / Phase 3 | Not yet recruiting | Mayo Clinic | 50 | 2026-10-01 | 2026-09-11 |
| Endocannabinoids in Reward Dronabinol, Placebo - Cannabis Use Disorder | Phase 2 | Recruiting | Medical University of South Carolina | 78 | 2026-10-01 | 2026-10-05 |
| Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery Cannabidiol (CBD) only, Placebo only, Delta-9-tetrahydrocannabinol (THC) only - PTSD, Post Traumatic Stress Disorder | Phase 1 / Phase 2 | Not yet recruiting | Leslie Lundahl | 280 | 2026-09-01 | 2026-08-26 |
| DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea. IHL-42X: 2.5 mg dronabinol + 125 mg acetazolamide, IHL-42X: 5 mg dronabinol + 125 mg acetazolamide, IHL-42X: 7.5 mg dronabinol + 125 mg acetazolamide - Obstructive Sleep Apnea (OSA) | Phase 2 | Recruiting | Incannex Healthcare Ltd | 120 | 2026-07-21 | 2026-10-13 |
| To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease Dronabinol Oral Solution, Placebo Control - Agitation in Dementia | Phase 2 / Phase 3 | Not yet recruiting | Benuvia Therapeutics Inc. | 140 | 2026-05-01 | 2026-02-25 |
| Sex Differences in Neurobehavioral Response to THC Dronabinol, Placebo - Cannabis Use Disorder | Phase 2 | Terminated | Medical University of South Carolina | 5 | 2026-04-27 | 2026-10-06 |
| Pregnenolone as a Treatment for Cannabis Intoxication Cannabis, Pregnenolone 250 mg, Pregnenolone 500 mg - Cannabis Intoxication | Phase 2 | Recruiting | Johns Hopkins University | 20 | 2026-04-24 | 2026-09-29 |
| Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital Dronabinol Capsules, Placebo - Endometriosis, Endometriosis Related Pain | Phase 2 | Withdrawn | Baylor College of Medicine | 2026-04-01 | 2026-03-13 | |
| Cannabis (THC vs. CBD) in Multiple Sclerosis THC, CBD - Multiple Sclerosis | Phase 2 | Recruiting | University of Calgary | 30 | 2025-12-05 | 2026-09-15 |
| Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors Biospecimen Collection, Cannabidiol, Dronabinol - Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy | Phase 2 | Recruiting | City of Hope Medical Center | 120 | 2025-10-03 | 2025-12-05 |
| Warrior CARE: Cannabis Behavioral Health Tetrahydrocannabinol, Cannabidiol, Placebo - Post Traumatic Stress Disorder, Cannabis Use | Phase 1 / Phase 2 | Recruiting | Wayne State University | 500 | 2025-09-22 | 2026-08-07 |
| Multimodal Magnetoencephalography and Electroencephalography Exploration of the Acute Effects of THC Exposure on Neural Noise and Information Transmission Within Working Memory Networks THC, Placebo - THC | Phase 2 | Not yet recruiting | Yale University | 50 | 2025-08-31 | 2025-06-10 |
| DRonabinol Treatment of OSA Dronabinol - Obstructive Sleep Apnea | Phase 1 / Phase 2 | Recruiting | VA Office of Research and Development | 120 | 2025-08-25 | 2026-08-11 |
| Pilot fMRI Studies of Aging-Related Effects of THC THC, Placebo - THC | Phase 2 | Recruiting | Yale University | 10 | 2025-07-01 | 2025-10-09 |
| Unique Treatment of Oncology Pain in Advanced Cancer Trichomylin® capsule (5 mg delta-9-tetrahydrocannabinol: 5 mg cannabidiol: 5 mg cannabichromene) - Cancer Pain | Phase 2 | Completed | ZYUS Life Sciences Inc. | 11 | 2025-06-12 | 2026-09-01 |
| Use of a Product Containing the Cannabinoids CBD and THC as a Treatment Strategy for Alzheimer's Disease - Alzheimer's Disease and Cannabis Clinical Trial (DAZACANN) Open-Label Phase Cannabis 50 mg of CBD and 5 mg of THC - Alzheimer Disease (AD) | Phase 1 / Phase 2 | Active not recruiting | Federal University of Latin American Integration | 61 | 2025-04-07 | 2025-08-12 |
| Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain Dronabinol, Placebo - Sickle Cell Disease | Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 60 | 2025-04-03 | 2025-10-02 |
| Effects of THC on Alcohol Consumption and Neural Correlates of Reward Dronabinol Pill, Placebo - Cannabis Use Disorder | Phase 2 | Recruiting | University of Colorado, Denver | 28 | 2024-07-01 | 2024-08-19 |
| Dronabinol as an Adjunct for Reducing Pain Dronabinol, Placebo - Low Back Pain, Chronic Pain | Phase 2 | Recruiting | Christopher D. Verrico | 75 | 2024-06-15 | 2026-05-18 |
Showing 20 of 86. Sign in to see all of them.
Marijuana Abuse (25) · Pain (7) · Chronic Pain (6) · Sleep Apnea, Obstructive (5) · Alzheimer Disease (4) · Multiple Sclerosis (4) · Abdominal Pain (3) · Dementia (3) · HIV Infections (3) · Marijuana Smoking (3) · Marijuana Use (3) · Nausea (3) · Neuralgia (3) · Stress Disorders, Post-Traumatic (3) · Vomiting (3)
New York State Psychiatric Institute (7) · University of California, San Diego (6) · Radboud University Medical Center (5) · Johns Hopkins University (4) · Mayo Clinic (3) · Yale University (3) · Incannex Healthcare Ltd (2) · Medical University of South Carolina (2) · University of Chicago (2) · University of Colorado, Denver (2) · VA Office of Research and Development (2) · Alberta Health services (1) · Baylor College of Medicine (1) · Benuvia Therapeutics Inc. (1) · Brigham and Women's Hospital (1)
United States (56) · Canada (8) · Netherlands (6) · Israel (3) · Australia (2) · Brazil (2) · Germany (2) · Austria (1) · Colombia (1) · Spain (1)
Margaret Haney, Ph.D. (3) · Godfrey Pearlson, M.D (2) · Harry van Goor, MD PhD (2) · Jon E Grant, JD, MD, MPH (2) · Michael Camilleri, MD (2) · Nathaniel M Schuster, MD (2) · Ryan Vandrey, Ph.D. (2) · Adam Bisaga, MD (1) · Alexander Kaplan (1) · Alexandre O Kaup, MD, PhD (1) · Antonio Vigano, MD, MSc (1) · Bernard Le Foll, MD, PhD (1) · Bharati Prasad, MD (1) · Brent Forester (1) · Cecilia Costiniuk, MD, MSc (1)
PMID 27720917, PMID 34532852, PMID 21343383, PMID 21590520, PMID 21803011, PMID 22288893, PMID 22921474, PMID 23188041, PMID 23831756, PMID 25220020, PMID 27159993, PMID 29121334, PMID 29457671, PMID 29689485, PMID 29870396, PMID 30659041, PMID 32178232, PMID 33660625, PMID 33730032, PMID 34582562, PMID 34629131, PMID 34825898, PMID 36877132, PMID 37692969, PMID 40772417, PMID 41350162, PMID 41469488, PMID 42267534, PMID 42524865, PMID 42631643
P50DA009236 (3), R01DA025044 (2), R01DK079866 (2), UL1RR024150 (2), K01DA049219 (1), K12DA031794 (1), K23HL151884 (1), P30CA033572 (1), P60DA005186 (1), R01AG050515 (1), R01AT010381 (1), R01AT011341 (1), R01DA019239 (1), R01DA027124 (1), R01DA038634 (1)